author-photo

Aparna Krishnan

City of Hope National Medical Center

8

Papers

89

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

PRELIMINARY RESULTS OF A PHASE 1 DOSE ESCALATION STUDY OF THE FIRST-IN-CLASS ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC), STRO-001, IN ADVANCED B-CELL MALIGNANCIES

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

2013 Leukemia
Show All
- Source
- Cite
- Save
Citations (30)
Phase II Trial of SCIO-469 as Monotherapy (M) or in Combination with Bortezomib (MB) in Relapsed Refractory Multiple Myeloma (MM).

2006 Blood
Show All
- Source
- Cite
- Save
Citations (16)
Phase 1 Clinical Trial of KOS-953 + Bortezomib (BZ) in Relapsed Refractory Multiple Myeloma (MM).

2005 Blood
Show All
- Source
- Cite
- Save
Citations (12)
Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (4)